Eikon Therapeutics, Inc. EIKN
5.84 USD -0.55 (-8.61%)
At closeNov 5, 2026, 4:00 PM EST
5.50 -0.34 -5.82%
After hours · Nov 5, 4:00 PM ET
5.75 Day range 6.43
5.01 52-week range 17.40
- YTD
- -61.07%
- 1 year
- -61.07%
Financial health
Rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 4
Valuation
P/E -2.4×
FY 2025 5y median -2.4× FY 2025
P/S 0.0×
FY 2025 5y median 0.0× FY 2025
P/B -0.9×
FY 2025 5y median -0.9× FY 2025
P/FCF -3.5×
FY 2025 5y median -3.5× FY 2025
EV/EBITDA -3.2×
FY 2025 5y median -3.2× FY 2025
EV/Sales 0.0×
FY 2025 5y median 0.0× FY 2025
FCF Yield -29.0%
FY 2025 5y median -29.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2025 5y median 0.0% FY 2025
ROE 36.9%
FY 2025 5y median 36.9% FY 2025
ROIC -61.7%
FY 2025 5y median -61.7% FY 2025
ROA -54.5%
FY 2025 5y median -54.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025 FY 2025
Financial Health
Current Ratio 6.3×
FY 2025 5y median 6.3× FY 2025
Quick Ratio 6.3×
FY 2025 5y median 6.3× FY 2025
Debt / Equity -0.3×
FY 2025 5y median -0.3× FY 2025
Net Debt / EBITDA -0.5×
FY 2025 5y median -0.5× FY 2025
Interest Coverage -405×
FY 2025 5y median -405× FY 2025
Dividends
Dividend Yield 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31